Peripheral Nerve Stimulation Pioneer Dr. Marc Huntoon Joins
CLEVELAND, Aug. 02, 2022 (GLOBE NEWSWIRE) — SPR Therapeutics is proud to announce the addition of Dr. Marc Huntoon to the corporate as Director of Medical Affairs. On this function, he’ll present perception to broaden the understanding and use of peripheral nerve stimulation (PNS) in treating sufferers residing with ache. Dr. Huntoon brings over 30 years of expertise in ache medication and neuromodulation to this function together with in depth management and instructing of minimally-invasive strategies inside the ache group.
“I’m happy to be becoming a member of the dedicated crew at SPR. I’ve been and actively working with PNS because the early 2000’s and having the chance to be part of the continued evolution of this remedy and particularly the SPRINT® System is thrilling,” stated Dr. Huntoon. “I sit up for working intently with the crew at SPR and our doctor colleagues to proceed to optimize the supply of PNS to satisfy the wants of sufferers by way of data-driven analysis, improvement, and innovation.”
Dr. Huntoon has held ache medication management roles at Virginia Commonwealth College, the Mayo Clinic, and Vanderbilt College. He’s energetic within the tutorial world as an writer with an intensive record of publications, speaks extensively on the historic and future use of minimally invasive PNS, and has served because the Editor-in-Chief of Regional Anesthesia and Ache Drugs. His dedication to ongoing studying and doctor management additionally consists of skilled society management and Board roles with the American Society of Regional Anesthesia and Ache Drugs (ASRA), the North American Neuromodulation Society (NANS), and American Academy of Ache Drugs (AAPM), together with being honored with the Distinguished Service Award from ASRA in 2020.
“We’re honored to have Dr. Huntoon be part of SPR as we attempt to raise our data in how we are able to greatest deliver ache aid to the sufferers we serve and set up SPRINT because the main, minimally-invasive choice,” stated Maria Bennett, CEO at SPR Therapeutics. “Dr. Huntoon has an incredible catalog of expertise, is well-respected all through the trade, is enthusiastic about PNS and will probably be an amazing addition to our crew.”
In regards to the SPRINT® PNS System
The SPRINT® PNS System, by SPR® Therapeutics, marks an progressive shift within the therapy of ache. Our breakthrough, 60-day therapy is a First-Line™ PNS choice uniquely designed to recondition the central nervous system to present important and sustained aid from continual ache — with out a everlasting implant, nerve destruction or the danger of dependancy. The system has been studied extensively for low again ache, shoulder ache, post-amputation ache, and continual and acute post-operative ache, and is cleared to be used as much as 60 days. Acknowledged by main ache administration facilities, the breakthrough neuromodulation therapy presents a patient-preferred various to extra invasive choices.
The SPRINT PNS System is indicated for as much as 60 days for: Symptomatic aid of continual, intractable ache, post-surgical and post-traumatic acute ache; symptomatic aid of post-traumatic ache; symptomatic aid of post-operative ache. The SPRINT PNS System is just not meant to deal with ache within the area innervated by the cranial and facial nerves.
Physicians ought to use their greatest judgment when deciding when to make use of the SPRINT PNS System. For extra info see the SPRINT PNS System IFU. Commonest adversarial occasions are pores and skin irritation and erythema. Outcomes could range. Rx solely.
For extra info concerning security and efficacy, go to www.SprintPNS.com.
About SPR Therapeutics, Inc.
SPR Therapeutics is a privately held medical machine firm, offering sufferers with a non-opioid, minimally invasive ache therapy choice. Our SPRINT® PNS System fulfills a important unmet want for a drug-free, surgery-free choice for tens of millions who are suffering from continual ache. Backed by the most important physique of medical proof in peripheral nerve stimulation for the therapy of ache SPR has demonstrated industrial demand in untapped peripheral (shoulder and knee) and again ache markets and constructed an extremely robust basis for industrial progress. Headquartered in Cleveland, OH with satellite tv for pc workplaces in Chapel Hill, NC and Minneapolis, MN, SPR’s Senior Administration crew consists of skilled trade veterans with almost 200 years of collective ache market and MedTech experience, all pushed by our objective – to enhance the standard of sufferers’ lives by offering them with a minimally-invasive, drug-free, surgery-free answer to handle their acute and continual ache.
Extra info might be discovered at www.SPRTherapeutics.com.
